TCGX
Science-driven investment firm dedicated to advancing disruptive medicines in biotech.
Palo Alto, United States · 17+ investments · 35 portfolio companies
- Headquarters
- Palo Alto, United States
- Founded
- 2021
- Website
- tcgcrossover.com
- AUM
- $5.1B
- Portfolio Companies
- 35
- Total Investments
- 17
- Last Investment
- Aug 2026
- Geographic Focus
- United States, Europe, China
Investment Thesis
TCGX is a Venture Capital firm based in Palo Alto, United States. It has made 17 investments, including Entrada Therapeutics, Korsana and Candid Therapeutics. Focus areas include Biotech and Healthcare.
Portfolio35
Co-investors24
Sign up to view co-investors
24 co-investors across 103 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×19 · Other ×3 · Hedge Fund ×1 · 27 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/tcgx"><img src="https://indexed.vc/api/badge/investor/tcgx" alt="TCGX on Indexed.vc" width="260" height="76" /></a>